4 August 2021News

Markel hails “outstanding performance” across business as H1 profits soar

Markel saw its second quarter profits dip year on year, but turned around a first half loss in 2020 to deliver a hefty H1 profit, as its co-chief executive officers hailed an outstanding performance across the business.

Markel reported a comprehensive profit of $849.7 million for Q2 2021, down from $1.09 billion in the same period the previous year. For the first six months of 2021, however, profit was up to $1.21 billion, having made a $260.4 million loss in the same period of 2020.

Earned premiums were up in Q2 2021, to $1.57 billion, from $1.36 billion in Q2 2020. For H1 2020 Markel reported earned premiums of $3.06 billion, up from $2.69 billion the previous year.

Meanwhile, the re/insurer’s combined ratio inched down to 87 percent in Q2 2021, from 88 percent the previous year. For the first six months of the year it fell to 90 percent, from 103 percent in H1 2020.

Thomas Gayner and Richard Whitt, Markel’s co-chief executive officers, said the results reflect the company’s outstanding performance across its three engines. “We continued to achieve double-digit premium growth in our underwriting operations through both organic growth in new business and more favorable rates,” they said.

“Markel Ventures revenues surpassed $1 billion for the quarter, which translated to an equally impressive contribution to our bottom line. Within our investment portfolio, significant gains on our equity portfolio demonstrate the quality of the portfolio as well as the value of our long-term focus, particularly in a volatile market.”




More on this story

News
16 September 2021   AM Best cites the strength of Markel NA business and underwriting outperformance.
News
28 September 2021   Deal will accelerate return of capital to investors to see off claims.

More on this story

News
16 September 2021   AM Best cites the strength of Markel NA business and underwriting outperformance.
News
28 September 2021   Deal will accelerate return of capital to investors to see off claims.